News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
348,618 Results
Type
Article (19500)
Company Profile (107)
Press Release (329009)
Multimedia
Podcasts (35)
Webinars (9)
Section
Business (91899)
Career Advice (770)
Deals (14666)
Drug Delivery (55)
Drug Development (49629)
Employer Resources (47)
FDA (7694)
Job Trends (7280)
News (163864)
Policy (14290)
Tag
2027 BioCapital Standard (1)
2027 BioMidwest Elite (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Biotech Beach Standard (1)
2027 Genetown Elite (2)
2027 Genetown Standard (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (2)
Academia (1682)
Accelerated approval (31)
ADA (49)
Adcomms (15)
Allergies (107)
Alliances (22543)
ALS (152)
Alzheimer's disease (1388)
Antibody-drug conjugate (ADC) (336)
Approvals (8099)
Artificial intelligence (347)
ASCO (195)
Autoimmune disease (254)
Automation (37)
Bankruptcy (154)
Best Places to Work (6224)
BIO (60)
BIOSECURE Act (14)
Biosimilars (85)
Biotechnology (84)
Bladder cancer (172)
Brain cancer (44)
Breast cancer (519)
Cancer (4101)
Cardiovascular disease (332)
Career advice (660)
Career pathing (19)
CAR-T (256)
CDC (27)
Celiac Disease (1)
Cell therapy (668)
Cervical cancer (28)
Clinical research (44297)
Collaboration (1261)
Company closure (2)
Compensation (696)
Complete response letters (44)
COVID-19 (1381)
CRISPR (68)
C-suite (734)
Cystic fibrosis (95)
Data (6514)
Denatured (3)
Depression (102)
Dermatology (55)
Diabetes (471)
Diagnostics (3266)
Digital health (22)
Diversity (1)
Diversity, equity & inclusion (17)
Drug discovery (218)
Drug pricing (61)
Drug shortages (19)
Duchenne muscular dystrophy (224)
Earnings (39717)
Editorial (30)
Employer branding (2)
Employer resources (45)
Events (57950)
Executive appointments (643)
FDA (10214)
Fibrodysplasia Ossificans Progressiva (8)
Friedreich's ataxia (18)
Frontotemporal dementia (30)
Funding (1062)
Gene editing (147)
Generative AI (31)
Gene therapy (552)
GLP-1 (652)
Government (2286)
Grass and pollen (1)
Guidances (295)
Healthcare (9115)
Hematology (130)
HIV (49)
Huntington's disease (38)
Idiopathic pulmonary fibrosis (1)
IgA nephropathy (90)
Immunology and inflammation (146)
Immuno-oncology (60)
Indications (132)
Infectious disease (1585)
Inflammatory bowel disease (149)
Inflation Reduction Act (4)
Influenza (75)
Intellectual property (199)
Interviews (99)
IPO (7509)
IRA (17)
Job creations (1286)
Job search strategy (591)
JPM (15)
Kidney cancer (17)
Labor market (36)
Layoffs (181)
Leadership (13)
Legal (2676)
Liver cancer (58)
Longevity (22)
Lung cancer (521)
Lymphoma (352)
Machine learning (39)
Management (17)
Manufacturing (594)
Marketing (3)
MASH (225)
Medical device (5263)
Medtech (5342)
Mergers & acquisitions (7879)
Metabolic disorders (1150)
mRNA (101)
Multiple sclerosis (135)
NASH (20)
Neurodegenerative disease (302)
Neuropsychiatric disorders (53)
Neuroscience (2455)
Neurotech (1)
NextGen: Class of 2026 (2908)
Non-profit (2219)
Now hiring (68)
Obesity (459)
Opinion (130)
Ovarian cancer (168)
Pain (182)
Pancreatic cancer (227)
Parkinson's disease (283)
Partnered (13)
Patents (353)
Patient recruitment (535)
Peanut (42)
People (30854)
Pharmaceutical (18)
Pharmacy benefit managers (9)
Phase 1 (13980)
Phase 2 (20004)
Phase 3 (14161)
Pipeline (6657)
Policy (130)
Postmarket research (1506)
Preclinical (6402)
Press Release (52)
Prostate cancer (197)
Psychedelics (23)
Radiopharmaceuticals (176)
Rare diseases (699)
Real estate (2311)
Recruiting (20)
Regulatory (12560)
Reports (19)
Research institute (1300)
Resumes & cover letters (117)
Rett syndrome (41)
RNA editing (13)
RSV (53)
Schizophrenia (122)
Series A (174)
Series B (125)
Service/supplier (3)
Sickle cell disease (82)
Special edition (4)
Spinal muscular atrophy (107)
Sponsored (20)
Startups (1780)
State (1)
Stomach cancer (5)
Supply chain (58)
Tariffs (24)
The Weekly (31)
Vaccines (524)
Venture capital (48)
Weight loss (251)
Women's health (65)
Worklife (5)
Date
Last 7 days (281)
Last 30 days (1256)
Last 365 days (18086)
2026 (9742)
2025 (17928)
2024 (20414)
2023 (22623)
2022 (27709)
2021 (29873)
2020 (27042)
2019 (22135)
2018 (16828)
2017 (16057)
2016 (14962)
2015 (17795)
2014 (12882)
2013 (10098)
2012 (11051)
2011 (11704)
2010 (10529)
Location
Africa (343)
Alabama (69)
Alaska (1)
Arizona (123)
Arkansas (8)
Asia (18903)
Australia (4051)
California (8787)
Canada (2305)
China (821)
Colorado (308)
Connecticut (352)
Delaware (253)
Europe (45695)
Florida (1149)
Georgia (264)
Hawaii (3)
Idaho (30)
Illinois (646)
India (59)
Indiana (434)
Iowa (14)
Japan (352)
Kansas (83)
Kentucky (24)
Louisiana (40)
Maine (38)
Maryland (909)
Massachusetts (6140)
Michigan (223)
Minnesota (409)
Mississippi (4)
Missouri (66)
Montana (22)
Nebraska (18)
Nevada (91)
New Hampshire (42)
New Jersey (2327)
New Mexico (10)
New York (2313)
North Carolina (1080)
North Dakota (9)
Northern California (4516)
Ohio (227)
Oklahoma (9)
Oregon (24)
Pennsylvania (1636)
Puerto Rico (21)
Rhode Island (14)
South America (477)
South Carolina (26)
South Dakota (1)
Southern California (3527)
Tennessee (121)
Texas (1339)
United States (29797)
Utah (224)
Vermont (1)
Virginia (208)
Washington D.C. (32)
Washington State (859)
West Virginia (4)
Wisconsin (60)
348,618 Results for "virginia biotechnology association vabio".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Sana Biotechnology Announces Symposium Presentation at the European Association for the Study of Diabetes (EASD) Annual Meeting 2026
July 1, 2026
·
3 min read
Manufacturing
Lilly to Bring Nearly 2,500 Jobs to Virginia With $5B Manufacturing Plant
This manufacturing site in Richmond, Virginia, is the first of four projects that Eli Lilly plans to reveal this year as part of a $27 billion U.S. investment announced earlier this year.
September 17, 2025
·
1 min read
·
Tristan Manalac
Press Releases
Vir Biotechnology to Present Complete Week 96 Data from Phase 2 SOLSTICE Clinical Trial in Hepatitis Delta at the European Association for the Study of the Liver (EASL) Congress 2026
May 18, 2026
·
4 min read
Press Releases
Lilly announces plans to build $5 billion manufacturing facility in Virginia
September 17, 2025
·
7 min read
Press Releases
Merck Breaks Ground on $3 Billion Center of Excellence for Pharmaceutical Manufacturing in Elkton, Virginia
October 21, 2025
·
6 min read
Press Releases
MingMed Biotechnology Presents Positive Phase II Data of Oral QA102 for the Treatment of Intermediate Age-Related Macular Degeneration (AMD) at Association for Research in Vision and Ophthalmology (ARVO) 2026
May 6, 2026
·
2 min read
Press Releases
Augustine Therapeutics to Present Late-Breaking Poster at the American Diabetes Association’s 86th Scientific Sessions
June 2, 2026
·
2 min read
Press Releases
Junevity to Present Breakthrough Research on siRNA Therapeutics at American Aging Association’s 2026 Annual Meeting
May 27, 2026
·
3 min read
Drug Development
Kiromic BioPharma Adds Virginia Oncology Associates, PC as the Second Clinical Trial Site in the Ongoing Phase 1 Deltacel-01 Trial
Kiromic BioPharma, Inc. (OTCQB: KRBP) (“Kiromic” or the “Company”) announces that Virginia Oncology Associates, PC (Norfolk, Virginia) has been activated as the second clinical trial site in the Phase 1 Deltacel-01 trial evaluating Deltacel™ (KB-GDT-01), Kiromic’s allogeneic, off-the-shelf, Gamma Delta T-cell (GDT) therapy, in patients with non-small cell lung cancer (NSCLC).
March 1, 2024
·
5 min read
Business
Virginia Oncology Associates Chooses the Ivenix Infusion System from Fresenius Kabi
Fresenius Kabi announced today it has signed an agreement with Virginia Oncology Associates (VOA) under which VOA will purchase the Ivenix Infusion System to deliver medications for its patients.
September 14, 2023
·
3 min read
1 of 34,862
Next
